Ledger.Open graph →
SEC Form D · filed February 21, 2018

Verrica Pharmaceuticals Inc

Offering
$21.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Charlottesville, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

James C. Reebals · Charlottesville, VAExec · PromoterPaul B. Manning · Charlottesville, VADirector · PromoterJayson Rieger · Charlottesville, VAExec · Director · PromoterSean Stalfort · Charlottesville, VADirector · PromoterPrasad Phatak · New York, NYExec · PromoterJoshua Sherman · Menlo Park, CADirector · PromoterJohn Pietrzak · Rancho Santa Fe, CADirector · PromoterJohn Eggemeyer, Iii · Rancho Santa Fe, CAExec · Director · PromoterGlenn Oclassen · San Carlos, CADirector · PromoterJoseph Bonaccorso · Charlottesville, VAExecTed White · Charlottesville, VAExecAnthony C. Cavallo · Charlottesville, VAExecMatthew Davidson · San Carlos, CAExec · Director · PromoterArthur M. Krieg · Cambridge, MAExec · PromoterScott Lenet · Los Angeles, CADirector · PromoterDaniel Katz · New York, NYDirector · PromoterDaniel Kaufthal · New York, NYExec · Director · PromoterGlenn Oclassen · San Carlos, CADirector · PromoterJoseph Bonaccorso · Charlottesville, VAExecTed White · Charlottesville, VAExecAnthony C. Cavallo · Charlottesville, VAExecMatthew Davidson · San Carlos, CAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗